Abiopharma

Fulcrum Therapeutics to Present at Upcoming Investor Meetings

Compass Therapeutics to Participate in Upcoming September Investor Events

Alcon - Alcon to Present at 2025 Baird Global Healthcare Conference

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025

Alcon to Present at 2025 Baird Global Healthcare Conference

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss

Financial Statements and Related Announcement: Full Yearly Results

Indivior Notification

New Form 8-K - INDIVIOR PLC Filed: 2025-08-26 AccNo: 0001625297-25-000059 Size: 143 KB Item 2.05: Cost Associated with Exit or Disposal Activities

New Form 6-K - GSK plc Filed: 2025-08-26 AccNo: 0001654954-25-009996 Size: 5 MB

NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders

New Form 8-K - Venus Concept Inc. Filed: 2025-08-26 AccNo: 0001140361-25-032608 Size: 164 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal